These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 973177)

  • 21. Cyclophosphamide reduces neutrophilic alveolitis in patients with scleroderma lung disease: a retrospective analysis of serial bronchoalveolar lavage investigations.
    Kowal-Bielecka O; Kowal K; Rojewska J; Bodzenta-Lukaszyk A; Siergiejko Z; Sierakowska M; Sierakowski S
    Ann Rheum Dis; 2005 Sep; 64(9):1343-6. PubMed ID: 16100339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responders to cyclophosphamide: results of a single-centre analysis among systemic sclerosis patients.
    Becker MO; Schohe A; Weinert K; Huscher D; Schneider U; Burmester GR; Riemekasten G
    Ann Rheum Dis; 2012 Dec; 71(12):2061-2. PubMed ID: 22689320
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy of scleroderma with griseofulvin (author's transl)].
    Kobíková M; Stáva Z; Cerná M
    Cesk Dermatol; 1976 Aug; 51(4):224-6. PubMed ID: 788928
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies of the changes in elastic fibers of the skin in acroscleroderma before and after treatment with heparin].
    Chodorowska G
    Ann Univ Mariae Curie Sklodowska Med; 1984; 39():247-55. PubMed ID: 6336485
    [No Abstract]   [Full Text] [Related]  

  • 25. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis].
    Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA
    Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436
    [No Abstract]   [Full Text] [Related]  

  • 26. [General and local hormonal therapy in scleroderma].
    Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of 100-day treatment of generalized scleroderma with imuran].
    Czernielewski A; Olszewska Z
    Przegl Dermatol; 1973; 60(6):761-7. PubMed ID: 4769960
    [No Abstract]   [Full Text] [Related]  

  • 28. [Penicillamine in the treatment of scleroderma].
    Kobíková M; Stáva Z
    Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784
    [No Abstract]   [Full Text] [Related]  

  • 29. Severe fibrin and crescent glomerulonephritis: clinical and morphological aspects of 33 patients.
    Mathew TH; Kincaid-Smith P
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):727-34. PubMed ID: 4803314
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of systemic scleroderma with fucidin in relation to clinical evaluation and analysis of free amino acids in the serum].
    Rubisz-Brzezińska J; Zebracka T; Mozdzanowska K; Mozdzanowski J
    Przegl Dermatol; 1986; 73(4):305-11. PubMed ID: 3333865
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)].
    Bröll H; Tausch G; Eberl R
    Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cyclophosphamide pulse therapy for pediatric systemic sclerosis].
    Iwata N; Miyamae T; Imagawa T; Katakura S; Mori M; Aihara Y; Yokota S; Kondo M; Sasaki T; Ikezawa Y
    Ryumachi; 2003 Oct; 43(4):660-6. PubMed ID: 14598659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of juvenile systemic sclerosis in Japanese.
    Murata M; Sato S; Komura K; Shirasaki F; Hasegawa M; Takehara K
    J Rheumatol; 2005 Sep; 32(9):1850-2. PubMed ID: 16142890
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experience using d-penicillamine in systemic scleroderma].
    Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP
    Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative evaluation of the effectiveness of cyclic polychemotherapy and continuous treatment of lupus nephritis with 2 immunodepressants].
    Demin AA; Sentiakova TN
    Ter Arkh; 1979; 51(1):71-6. PubMed ID: 556551
    [No Abstract]   [Full Text] [Related]  

  • 37. [Tramadol in the vascular pains of patients with systemic scleroderma and other rheumatic diseases].
    Guseva NG; Alekperov RT; Anikina NV
    Ter Arkh; 1994; 66(1):20-4. PubMed ID: 8146787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of colchicine in progressive systemic sclerosis].
    Tanimoto K; Oohama Y; Yamada A; Moroi Y; Matsuo H
    Ryumachi; 1977 Jan; 17(1):56-62. PubMed ID: 847544
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.
    Mittal G; Udwadia Z; Joshi VR
    J Rheumatol; 2003 May; 30(5):1121-2; author reply 1122. PubMed ID: 12734923
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of collagenoses with cytostatic agents].
    Klabusay L
    Vnitr Lek; 1980 Oct; 26(10):941-6. PubMed ID: 6110279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.